DFI Mentored Junior Faculty Fellowship

Training the next generation is as critical as supporting the current generation.  For this reason, the Duncan Family Institute established its Mentored Junior Faculty Fellowship to support the earliest stages of a faculty member’s career and fill that critical gap in funding between a postdoctoral training position and a faculty tenure track position as the assistant professor level.  The research of our current fellows ranges from the neurobiology of addiction and the potential for new insights into effective tobacco cessation interventions to investigations into the factors that influence physical activity behaviors in Mexican American adolescents, which can serve to inform development of new interventions and public policies to promote adoption of healthy lifestyles.

Thanh Bui, M.D., Dr.P.H., Instructor, Behavioral Science
October 2014

Hygienic sexual Practices and HPV Prevention


Diana Stewarat, Ph.D., Instructor, Health Disparities Research
September 2013

Reducing Tobacco-Related Cancer Disparities in the Underserved


Claire Adams, Ph.D., Instructor, Health Disparities Research
June 2012

“Mindfulness-Based Strategies for Improving Cancer Risk Behaviors”


Meng Chen, Ph.D., Instructor, Epidemiology
September 2012

“Gene set enrichment analysis of bladder cancer genome wide scan”


Jian Wang, Ph.D., Instructor, Biostatistics
September 2011

“Risk modeling using mediation analysis and Bayesian network recovery with application to smoking cessation study”


Larkin Strong, Ph.D., Assistant Professor, Health Disparities Research
December 2010

"An ecological approach to cancer prevention: Reducing disparities in physical activity through research and action"


Francesco Versace, Ph.D., Assistant Professor, Behavioral Science 
April 2010

"Putting smoking addiction in the affective context: Event-related potentials to emotional and neutral stimuli during a smoking cessation intervention”


Thanh Bui, M.D., Dr.P.H.

"Hygienic Sexual  Practices and HPV Prevention"

Infection with human papillomavirus (HPV) is an established cause of more than 30,000 cases of cancers each year in the United States (US), including cancers of the cervix, vagina, vulva, penis, oropharynx and anal canal. Typical risk factors associated with oral HPV infection include oral sex, number of lifetime sex partners, and cigarette smoking. One major “frame” in HPV research is that HPV is often considered a sexually transmitted infection (STI), and it is the most common STI in the world. Although this is true, viewing HPV in this manner is somewhat constraining because it drives the focus of intervention research on safe sexual practices (e.g. condom use, reducing numbers of sexual partners), and other means of preventing HPV transmission than safe sex then remain unexplored or underemphasized.

Dr. Bui’s main research focus is to explore additional risk factors for HPV infection, and to look for novel behavioral interventions for HPV prevention. Specifically, Dr. Bui’s research examines the effect of hygiene practices and their interactions with sexual practices on HPV infection at different body sites. Examining these behavioral factors is important because they are all modifiable. Thus, the research’s results will inform future novel widely-usable interventions to change the behaviors in order to reduce HPV infection, persistence, and subsequent HPV-related cancers. Dr. Bui is also interested in applying innovation generation tools to the development and assessment of other behavioral interventions to promote early cancer prevention.

Diana Stewart, Ph.D.

"Reducing Tobacco-Related Cancer Disparities in the Underserved"

One-third of U.S. cancer-related deaths and 90% of lung cancer cases result from tobacco smoking. Although smoking prevalence has declined in recent years, it remains high for certain populations such as racial/ethnic minorities and those with low income, education, and employment. Such high-risk groups are less likely to quit smoking and often have less access to cessation resources. Thus, smoking has a major impact on cancer-related morbidity and mortality within these vulnerable populations.

The primary focus of Dr. Stewart’s research project is to evaluate a model exploring mediators (i.e., depression, social support)of the relation between health literacy and smoking cessation outcomes in low-SES, racially/ethnically diverse smokers enrolled in cessation treatment. Findings will elucidate the effects of health literacy on depression and cessation outcomes, and will be critical for informing and improving cessation programs, thus reducing tobacco-related health disparities. Dr. Stewart is also conducting a qualitative study to examine ways of enhancing the adoption and implementation of Ask Advise Connect (AAC), an evidence-based approach linking smokers in healthcare settings with treatment, in the Harris Health System community health centers. These findings have the potential to increase cessation rates at the population level.

Claire Adams, Ph.D.

Mindfulness-Based Strategies for Improving Cancer Risk Behaviors”

Tobacco use, alcohol use, and unhealthy eating have each been linked to increased risk of cancer and/or cancer-related mortality. Because these health risk behaviors tend to cluster together (e.g., smokers display more, and more serious, health risk behaviors than nonsmokers), there is an urgent need to target multiple health risk behaviors to prevent cancer. Dr. Adams' research seeks to inform behavioral interventions to reduce unhealthy behaviors (i.e., smoking, at-risk alcohol use, and unhealthy eating) linked to cancer risk and cancer-related mortality. She is interested in commonalities underlying disparate health risk behaviors and targeting these shared pathways to improve evidence-based interventions for multiple health behavior change (MHBC). In particular, her work focuses on mindfulness (paying attention to present-moment experience with an attitude of non-judgment and acceptance) as one promising avenue for targeting multiple health risk behaviors. Although preliminary research supports mindfulness-based treatments for improving smoking cessation, reducing relapse to alcohol use disorders, and promoting healthier eating, this area of research is in its infancy, and the mechanisms of mindfulness for health behavior change are unclear. There is also a lack of research on mindfulness in racial/ethnic minorities, who often have higher rates of cancer risk and related mortality.

Dr. Adams' research centers on developing and testing a moderated mediation model of mindfulness, negative affect, and health behavior to integrate different lines of mindfulness and health behavior research, elucidate mechanisms of mindfulness, and apply to racially/ethnically diverse populations.

Meng Chen, Ph.D.

Gene set enrichment analysis of bladder cancer genome wide scan”

Bladder cancer is the fourth most common cancer in men in the United States. It is an excellent model of studying genetic susceptibility and gene-environmental interaction. Smoking is responsible for about half of all the bladder cancer cases and occupational exposure accounts for approximately one fifth of the cases. Candidate gene approach has shown that genetic variants in carcinogen metabolism genes (e.g., NAT2 and GSTM1) predispose individuals to bladder cancer. Recent genome wide association studies (GWAS) have identified over 10 additional novel bladder cancer susceptibility loci. However, these confirmed bladder cancer susceptibility loci only explain a small fraction of the genetic heritability of bladder cancer. Identifying additional loci through innovative approaches is needed. Dr. Meng Chen has been involved in bladder cancer susceptibility, gene-smoking interaction, and clinical outcome research for several years by using candidate gene, pathway-based, and GWAS approaches. She will continue to focus on bladder cancer susceptibility study during her Duncan fellowship. One of her particular interests is to finding novel genes and pathways involved in bladder cancer susceptibility through the gene-set enrichment analysis (GSEA). A recurring problem in traditional GWAS analysis (i.e., single SNP analysis) is the lack of consideration of biological pathways that contain network of genes with subtle, undetectable effect at single SNP or single gene level. Application of innovative secondary analyses focusing on genes and pathways will complement and expand traditional GWAS analysis and identify genes and pathways that associate with bladder cancer risk. Dr. Chen has explored the genome wide scan data from MD Anderson bladder cancer case control study, the largest bladder cancer case-control study in U.S., to identify critical and novel pathways involved in bladder cancer etiology. She will validate her findings in independent populations. She will further analyze gene-gene and gene-environment interaction, and cumulative effect of these identified pathways.

The completion of this study may not only enhance the understanding of the overall gene networks involved in bladder cancer susceptibility but also offer additional etiologic insights highlighting the specific genes and pathways involved. It may identify druggable targets for cancer prevention and treatment and potentially improve the risk prediction model of bladder cancer. GSEA (gene set enrichment analysis) method will be a complementary tool to identify the “missing heritability” from previous GWAS, and can be widely applied in cancer association study and clinical outcome study.

Jian Wang, Ph.D.

Risk modeling using mediation analysis and Bayesian network recovery with application to smoking cessation study”

There are evidences that cigarette smoking is associated with cancers of lung, oral cavity, bladder, kidney, pancreas, stomach, etc. Smoking cessation results in decreased incidence and mortality from cancers, and therefore, is an important component of cancer prevention. Despite ever-increasing anti-smoking legislation and social pressure, the proportion of successful smoking cessation attempts is still low. Over 40% of current smokers make a serious cessation attempt each year, but only less than 3% of them successfully quit. The success of smoking cessation is associated with various genetic risk factors (e.g. genes related to dopamine pathways and nicotinic receptors), pharmacological treatments (e.g. bupropion), as well as the negative affect caused by quitting attempts (e.g. depression, irritation, and nervousness). The identification of novel risk factors and their interactions (gene-gene and gene-environmental interactions) can help our overall understanding of the complex mechanism for nicotine dependence, and therefore, help identify individuals at highest risk for the nicotine addition and response to therapy on the basis of their personal exposure patterns and their genetic risk profiles. The gene-environmental interaction is often defined as joint participation in the causal mechanism leading to disease. But more complex interactions exist, such as genetic factors that have no impact on disease risk alone but become risk factors when combined with environmental factors or genetic factors that have an impact on disease by dual pathways, independently and through interaction with environmental factors. Therefore, it is crucial to identify the complex relationships among risk factors and their effects on smoking cessation.

Dr. Wang’s research proposes to develop new statistical approaches for modeling the risk of smoking cessation, which will identify the complex relationships among genetic variants, environmental risk factors (e.g., number of smokers in family and social context), and smoking cessation based on two rigorous statistical approaches: mediation analysis and Bayesian network recovery approaches. Specifically, she will identify the mediating/moderating effects of the negative affect due to quitting attempts and pharmacological treatments on the association between genetic variants and smoking cessation. The resulting statistical model will provide a novel tool for the development and tailoring of both prevention strategies for individuals at risk and effective pharmacologic interventions for current smokers and, therefore, contribute to the prevention of related cancers.

Larkin Strong, Ph.D.

"An ecological approach to cancer prevention: Reducing disparities in physical activity through research and action"

Physical inactivity represents one of the few modifiable risk factors for cancer. Regular physical activity is associated with a reduced risk of breast and colon cancers and has also been linked to reductions in prostate, lung, and endometrial cancer risk. Inactivity is also an important determinant of overweight and obesity, which are believed to contribute to 15-20% of all cancer deaths in the U.S. Given that physical activity behaviors established in youth may continue into adulthood, enhancing physical activity in youth has the potential to greatly reduce the cancer burden in the U.S through direct and indirect pathways. Furthermore, since physical activity tends to decline dramatically during adolescence, adolescence represents a critical age during which to identify the factors that contribute to or inhibit participation in physical activity. 

The focus of Dr. Strong’s research project is to delineate how factors at different levels influence adolescent physical activity (PA) behaviors in a group of 1,154 Mexican American adolescents in Houston, TX, drawn from the Duncan Family Institute’s Mexican American Cohort.  In this research project, Dr. Strong and colleagues seek to understand the independent contributions and interactions of multiple factors on physical activity:  adolescent characteristics & behaviors, parental characteristics and behaviors, neighborhood socioeconomic context and density of neighborhood PA resources; and identify potential targets for interventions to enhance physical activity in this population.   By drawing on unique data that includes parental and adolescent measures of  linguistic and behavioral acculturation and characteristics of adolescents’ neighborhood environments, findings from this research will have important implications for the design of family-based physical activity interventions for Mexican American families and will help to identify the importance of community physical activity resources to adolescent physical activity.  Furthermore, this research may identify segments of the population who may be more affected by local environmental features, helping policy makers and funders target public health investments to where they will have the greatest impact.

Francesco Versace, Ph.D.

Putting smoking addiction in the affective context: Event-related potentials to emotional and neutral stimuli during a smoking cessation intervention” 

Tobacco use is associated with approximately 80 percent of all lung cancer deaths and increases the risk of many other types of cancer, including cancers of the throat, mouth, pancreas, kidney, bladder, and cervix (NCI, 2008).  Although the harmful effects of tobacco on human health have been known since the 1964 Surgeon General Report (Smoking and Health, 1964), approximately 20% of USA population continue to smoke (CDC, 2007).  In fact, most smokers identify tobacco use as harmful and express a desire to reduce or stop using it.  For example, annually nearly 35 million smokers express a desire to quit in national surveys.  Unfortunately, more than 85 % of those who actually try to quit on their own will relapse, often within the first week following the cessation attempt (NIDA, 2009).  The reasons underlying the maintenance of addiction are diverse, but most theoretical models attribute the difficulties in quitting to the smoker’s altered emotional processes.  Where theories differ is in the different emphasis that they attribute to specific emotional components to explain drug addiction and relapse.

The overarching theme of Dr. Versace’s research and the project described here is to investigate the role that emotional processes have in smoking addiction and relapse by taking advantage of the theoretical models, the experimental designs, and the measurement techniques developed within the field of affective neuroscience. Specifically, Dr. Versace and colleagues will evaluate attentional and emotional processes in the presence of cigarette-related and other intrinsically motivating cues using event-related brain potentials (ERP).  These ERP assessments will be carried out before and after a smoking cessation and will allow the evaluation of pharmacological smoking cessation aids (varenicline, bupropion and placebo) and their altering effects on emotional processes.

Larkin Strong, Ph.D.

The Duncan Family Institute helps Larkin Strong, Ph.D. investigates the contributing factors that influence physical activity and obesity in Mexican American adolescents. See video

Francesco Versace, Ph.D.

The Duncan Family Institute helps Dr. Francesco Versace test the relationships between negative affect and the maintenance of smoking behavior, cessation and relapse. See video

Fellowship Announcements and Guidelines

Investing in the next generation is a high priority of the Institute. Read more.